Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID March 4, 2026 4:15 ...

Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and ...

Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with ...

An ongoing Phase III trial aims to further evaluate the drug's clinical efficacy in reducing seizures and affecting behavior and cognition.

Grounded in unified data, new offering turns AI ambition into high-impact adoption through human-led expertise NEW ...

A pioneering gene therapy could help treat a rare seizure disorder called Dravet syndrome, according to new clinical trial ...

Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD , from Ann & Robert H. Lurie Children's Hospital of Chicago, show that the first ...

A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and well tolerated ...

Preliminary trials into Zorevunersen find drug to be safe and well tolerated by those with Dravet syndrome ...

Cerebral palsy is a condition usually caused by brain damage before or during birth, resulting in impaired posture and movement.

Explore groundbreaking research on cerebral palsy treatments that could offer new hope for affected children and families.

Researchers found that stem cells derived from human baby teeth improved motor skills, learning and brain repair in rats with ...